|
Video: What is a Stock Split?
|
|
Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused primarily on the development of therapeutic products for the treatment of cancer. Co.'s clinical-stage product candidates include ONT-380, an orally active and selective small-molecule HER2 inhibitor, and ONT-10, a therapeutic vaccine targeting the Mucin 1 peptide antigen. Co. also develops preclinical product candidates in oncology, and potentially certain rare diseases, using its acquired protocell technology. Co. also collaborates with partners to discover and develop additional product candidates. According to our ONTY split history records, ONTY has had 1 split. | |
|
ONTY (ONTY) has 1 split in our ONTY split history database. The split for ONTY took place on December 11, 2007. This was a 1 for 6 reverse split, meaning for each 6 shares of ONTY owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 166.666666666667 share position following the split.
When a company such as ONTY conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ONTY split history from start to finish, an original position size of 1000 shares would have turned into 166.666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ONTY shares, starting with a $10,000 purchase of ONTY, presented on a split-history-adjusted basis factoring in the complete ONTY split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
06/08/2016 |
|
Start price/share: |
$2.99 |
|
End price/share: |
$1.21 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-59.53% |
|
Average Annual Total Return: |
-33.82% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$4,046.43 |
|
Years: |
2.19 |
|
|
|
Date |
Ratio |
12/11/2007 | 1 for 6 |
|
|